Literature DB >> 13685389

Treatment of superficial fungous infections. Value and limitations of systemic administration of griseofulvin.

S AYRES, S AYRES.   

Abstract

Comprehensive studies and numerous clinical reports have shown that griseofulvin orally in a dose of 1 gm. daily is an effective treatment for superficial fungous infections of the skin, hair and nails. The drug is not effective against yeast infections (moniliasis), bacterial infections or most of the deep fungous infections. Duration of treatment varies with the site of infection, glabrous skin, crotch and scalp responding within four to five weeks. Infections of palms, soles and nails require a considerably longer time, palms healing more quickly than soles and fingernails more quickly than toenails, which may require up to a year of continuous treatment. Auxiliary measures such as clipping hair, removing infected nail tissue and topical fungicides shorten the duration of treatment. No serious side effects have been reported. Minor discomforts such as headaches and mild rashes occur in some cases. Observations of a series of 49 patients with superficial fungous infections, especially hand, foot and nail infections due to Trichophyton rubrum, confirmed these reports taken from the literature. Attempts to use a reduced dosage schedule did not prove satisfactory.

Entities:  

Keywords:  DERMATOMYCOSIS/therapy; GRISEOFULVIN/therapy

Mesh:

Substances:

Year:  1961        PMID: 13685389      PMCID: PMC1574439     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  12 in total

1.  Experiences in one hundred thirty-seven patients treated with oral griseofulvin. Special reference to clinical recurrences. the healthy carrier state, and their management.

Authors:  N J GOLDFARB; M B SULZBERGER
Journal:  Arch Dermatol       Date:  1960-05

2.  Effect of griseofulvin on Trichophyton rubrum and Trichophyton violaceum infections. Clinicomycological correlation of the mode of action in tissue.

Authors:  S C DESAI
Journal:  Arch Dermatol       Date:  1960-05

3.  Treatment of shoulder-hand syndrome with griseofulvin.

Authors:  A COHEN; J GOLDMAN; R DANIELS; W KANENSON
Journal:  J Am Med Assoc       Date:  1960-06-04

4.  Recurrence of Trichophyton rubrum infection during treatment with griseofulvin. Report of a case.

Authors:  C Z BERRY; S I SHAPIRO; R F DAHLEN
Journal:  Arch Dermatol       Date:  1960-06

5.  Griseofulvin for the systemic treatment of dermatomycoses.

Authors:  H BLANK; J G SMITH; F J ROTH; N ZAIAS
Journal:  J Am Med Assoc       Date:  1959-12-19

6.  Histopathologic evaluation of griseofulvin in Microsporum audouini infections.

Authors:  C F BURGOON; J H GRAHAM; R J KEIPER; F URBACH; J S BURGOON; E B HELWIG
Journal:  Arch Dermatol       Date:  1960-05

7.  The experimental toxicology of griseofulvin.

Authors:  G E PAGET; A L WALPOLE
Journal:  Arch Dermatol       Date:  1960-05

8.  Studies concerning the development of resistance to griseofulvin by dermatophytes.

Authors:  S A ROSENTHAL; R S WISE
Journal:  Arch Dermatol       Date:  1960-05

9.  Griseofulvin and human spermatogenesis.

Authors:  J MACLEOD; W O NELSON
Journal:  Arch Dermatol       Date:  1960-05

10.  Griseofulvin therapy for superficial fungus infections. Effect upon concurrent diseases.

Authors:  P LAZAR; H RATTNER
Journal:  Arch Dermatol       Date:  1960-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.